Empower Advisory Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Sell |
5,008
-225
| -4% | -$15.7K | ﹤0.01% | 376 |
|
|
2025
Q1 | $385K | Buy |
5,233
+188
| +4% | +$13.8K | ﹤0.01% | 355 |
|
|
2024
Q4 | $331K | Buy |
5,045
+1,381
| +38% | +$90.5K | ﹤0.01% | 387 |
|
|
2024
Q3 | $285K | Sell |
3,664
-4,259
| -54% | -$332K | ﹤0.01% | 412 |
|
|
2024
Q2 | $618K | Sell |
7,923
-2,789
| -26% | -$218K | ﹤0.01% | 279 |
|
|
2024
Q1 | $726K | Sell |
10,712
-472
| -4% | -$32K | ﹤0.01% | 256 |
|
|
2023
Q4 | $753K | Buy |
11,184
+749
| +7% | +$50.4K | ﹤0.01% | 251 |
|
|
2023
Q3 | $707K | Buy |
10,435
+94
| +0.9% | +$6.37K | ﹤0.01% | 254 |
|
|
2023
Q2 | $740K | Buy |
10,341
+397
| +4% | +$28.4K | ﹤0.01% | 256 |
|
|
2023
Q1 | $695K | Buy |
+9,944
| New | +$695K | ﹤0.01% | 270 |
|